Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer have?
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer has 369 citations in the OpenAlex counts ScholarIQ stores.
When was Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer published?
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer has 2016 year in the ScholarIQ index.
What is the open-access status of Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer?
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer?
The DOI for Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer is on the source record.
What is the PMID of Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer?
The PMID for Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer is on the source record.
What is the OpenAlex record for Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer?
The OpenAlex for Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer is on the source record.